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Polychlorinated biphenyls (PCBs), a class 
of 209 congeners with two linked phenyl 
rings and variable chlorination in different 
sites, were introduced in 1929. Before being 
banned in most industrialized countries in the 
late 1970s because of their persistence, PCBs 
were widely used as dielectric fluids in electri-
cal transformers and capacitors and as heat 
exchangers or hydraulic fluids (Agency for 
Toxic Substances and Disease Registry 2000). 
Although concentrations of PCBs, dioxin, 
and dibenzofurans in humans are declin-
ing (Fangstrom et al. 2005; Norén 1988; 
Schecter et al. 2005), their improper disposal 
has resulted in low-level environmental con-
tamination worldwide. Particularly affected 
are populations with significant contamina-
tion from past manufacturing and improper 
disposal (Hansen et al. 2003; Kocan et al. 
2001; Park et al. 2007) or those populations 
whose diet includes consumption of PCB-
contaminated fish or seafood (Dallaire et al. 
2004; Fangstrom et al. 2005).
PCBs are structurally related to 2,3,7,8-
tetra  chlorodibenzo-p-dioxin (TCDD, or 
“dioxin”), and depending on their particu-
lar chlorine substitution pattern, some con-
geners may produce health effects similar to 
TCDD (i.e., the so-called “dioxin-like” PCB 
congeners) (Van den Berg et al. 2006). In terms 
of their potential developmental immuno-
toxicity, TCDD and dioxin-like PCBs have 
well-  established effects on the immune system, 
one of which is thymic atrophy, an outcome 
observed in all species evaluated after TCDD 
exposure (Lawrence and Kerkvliet 2006). The 
thymus is a lymphoid organ responsible for 
T-cell differentiation and maturation and is 
seeded by lymphocyte stem cells that origi-
nate from the liver and yolk sac during ges-
tation and from bone marrow postnatally 
(Moore and Owen 1967). Although the exact 
mechanism by which TCDD-induced thymic 
atrophy occurs is not known, potential mecha-
nisms include a reduction in prothymocyte 
stem cells in the bone marrow and an inhi-
bition of thymocyte maturation (Silverstone 
et al. 1994), and induction of apoptosis in 
thymo  cytes (McConkey et al. 1988).
Although the immunologic effects of diox-
ins and PCBs are well documented in experi-
mental studies, potential effects on the human 
immune system are less well studied. A previ-
ous analysis from this cohort reported smaller 
thymus volumes at birth in relation to higher 
maternal serum PCB concentrations (Park 
et al. 2008), the first such study in humans. 
However, it is not known whether in utero 
and/or postnatal PCB exposures are associ-
ated with thymus volume later in infancy. The 
present study expands our investigation longi-
tudinally to an examination of infant thymus 
volume at 6 and 16 months of age, in a popu-
lation with substantial PCB exposure.
Materials and Methods
Study population and follow-up. Pregnant 
women were recruited for this study at the time 
of their admittance to the hospital for deliv-
ery (Hertz-Picciotto et al. 2003). Recruitment 
occurred between 2002 and 2004 in two dis-
tricts of eastern Slovakia: Michalovce, a region 
with substantial environmental contamination 
due to past manufacturing (Kocan et al. 2001); 
and Svidnik, a region located approximately 
70 km to the northwest, with less environ-
mental contamination and lower serum PCB 
concentrations among inhabitants (Petrik et al. 
2006). Because each district has only one hos-
pital, the vast majority of births to residents in 
these two districts occur in these hospitals. We 
excluded mothers who had more than four 
previous births, who were < 18 years of age 
at the time of delivery, who reported residing 
< 5 years in either district, or who had a major 
illness during pregnancy. Infants with severe 
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Ba c k g r o u n d: Previously, we reported an association between higher maternal polychlorinated 
biphenyl (PCB) concentrations and smaller thymus volume in newborns in a birth cohort residing 
in eastern Slovakia. 
oB j e c t i v e: In the present report we address whether thymus volume at later ages is influenced by 
prenatal and early postnatal PCB exposure.
Me t h o d s : At the time of delivery, 1,134 mother–infant pairs were enrolled. Maternal and 6- and 
16-month infant blood samples were collected and analyzed for 15 PCB congeners. Thymus volume 
was measured in infants shortly after birth and at ages 6 and 16 months using ultrasonography.
re s u l t s: Higher maternal PCB concentration was associated with reduced thymus volume at birth 
[a 0.21 SD reduction in thymus volume for an increase in total maternal PCB concentration from 
the 10th to the 90th percentile; 95% confidence interval (CI): –0.37, –0.05], whereas maternal 
PCB concentration was not predictive of 6- and 16-month thymus volume. Six-month infant PCB 
concentration was associated with a 0.40 SD decrease in 6-month thymus volume (95% CI: –0.76, 
–0.04). There was also some suggestion that thymus volume at 16 months was positively associated 
with concurrent infant PCB concentration.
co n c l u s i o n s: The potential adverse effects of in utero PCB exposure on thymic development may 
extend beyond the neonatal period. Results from this highly exposed cohort provide suggestive 
evidence that postnatal PCB concentrations may be influential, but a smaller set of 6-month PCB 
measurements limited statistical power at that time point. Implications regarding impaired immu-
nologic maturation or long-term clinical implications remain to be determined.
key w o r d s : atrophy, cohort, epidemiology, immune, Roma, T cell. Environ Health Perspect 
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birth defects were also excluded. Trained nurs-
ing staff at each hospital explained the study 
procedures, and all participants gave written 
informed consent.
All forms of communication were in 
the Slovak language. In total, 1,134 women 
were enrolled (811 in Michalovce and 323 in 
Svidnik). During the hospital stay, each infant 
underwent an ultrasound examination of the 
thymus. The study protocol was approved by 
institutional review boards at the University 
of California–Davis and the Slovak Medical 
University in Bratislava.
When the infants were approximately 
6 and 16 months of age, mother–infant 
pairs were invited back to the Department 
of Pediatrics at their local hospital in either 
Michalovce or Svidnik, where blood was col-
lected for PCB analysis and infants again 
underwent ultrasound examinations (described 
below). At the infants’ age 6 months, 971 
mother–infant pairs were still participating in 
the study (86%), and at age 16 months, 887 
(78%) were still participating.
Specimen collection. At the time of deliv-
ery, two 9-mL Vacutainer tubes were used 
to collect maternal blood, and at the 6- and 
16-month follow-ups, approximately 9 mL of 
blood was collected from the infant. Details 
on the processing, transport, and storage of 
specimens and the isolation of serum have 
been published elsewhere (Jusko et al. 2010).
PCB and lipid measurement. The concen-
trations of 15 PCB congeners [International 
Union of Pure and Applied Chemistry 
(IUPAC) PCB congeners 28, 52, 101, 105, 
114, 118, 123+149, 138+163, 153, 156+171, 
157, 167, 170, 180, and 189] were determined 
in maternal and 6- and 16-month serum sam-
ples. The procedure for determination of PCB 
concentrations involved extraction, cleanup, 
and quantitation by high-resolution gas chro-
matography with electron capture detection; 
specifics of the analysis are detailed elsewhere 
(Conka et al. 2005; Jusko et al. 2010). PCB 
congeners 123+149, 138+163, and 156+171 
coeluted on the gas chromatograph column. 
The Department of Toxic Organic Pollutants 
at the Slovak Medical University in Bratislava 
performed the laboratory analyses. This labora-
tory has participated in intercalibration studies 
organized by the World Health Organization 
(WHO) and the German Agency for 
Occupational and Environmental Medicine 
(Deutsche Gesellschaft fuer Arbeitsmedizine 
und Umweltmedizin e.V.). Total serum lip-
ids were measured at a biochemical laboratory 
accredited by the Slovak National Accreditation 
Service located at the Ministry of Defense mili-
tary hospital in Bratislava, and total lipid con-
centrations were estimated using the enzymatic 
summation method (Akins et al. 1989).
Maternal PCBs were analyzed for 1,104 
women. At age 6 months, 249 infant specimens 
were selected for analysis based on their cor-
responding maternal PCB concentration. 
Specifically, 6-month infant specimens were 
randomly sampled within strata defined by 
total maternal PCB concentrations: a) < 75th 
percentile, b) between 75th and 85th percen-
tiles, c) between 85th and 95th percentiles, 
and d) > 95th percentile (Jusko et al. 2010). At 
16 months of age, 831 infant serum specimens 
were analyzed (all available specimens).
Thymus measurement.  Thymus vol-
ume was measured by four radiologists from 
Michalovce and two radiologists from Svidnik 
using a sonographic scanner [Esaote 580 
FD Caris plus (convex probe 7.5 MHz) in 
Michalovce; Esaote AU 5 Harmonic (convex 
probe 7.5 MHz) in Svidnik; both from Esaote, 
Genoa, Italy]. The radiologists were unaware 
of maternal and infant PCB concentrations. 
Measurements of the thymus derived from 
sonographs are regarded as reliable, especially in 
young children (Hasselbalch et al. 1996, 1997). 
A transsternal approach was used to measure 
the maximal transverse diameter (width) of 
the thymus, and in the plane perpendicular 
to this width, the largest sagittal area (longi-
tudinal scan plan) was also measured. These 
two measurements were multiplied to obtain 
a “thymic index,” a proxy of thymus volume. 
The thymic index has been used as a surro-
gate for thymus volume, because it is strongly 
correlated (r ≥ 0.80) with the actual volume 
and weight of the thymus (Hasselbalch et al. 
1996) (hereafter, the thymic index is referred 
to as thymus volume). Thymus volume was 
measured in 1,074 newborns, 940 children 
6 months of age, and 820 children 16 months 
of age, for whom 1,020 (95%), 241 (26%), 
and 806 (98%) had PCB measurements.
Other data collection. Maternal question-
naire. During the 5-day hospital stay after 
delivery, trained nursing staff administered a 
questionnaire that obtained information on 
lifestyle and living environment, past pregnan-
cies and medical conditions, medication use 
during and before pregnancy, and sociodemo-
graphic data, including ethnicity. Ethnicity 
was categorized into two groups: Slovakian/
other eastern European or Romani. Romani 
ethnicity was attributed to the mother if the 
ethnic origin of either of her parents was 
Romani, the Romani language was spoken 
at the home of the child, or the mother was 
planning to raise her child with the Romani 
language. Romani ethnicity was subsequently 
independently confirmed by a Slovak mem-
ber of the research team who used additional 
information such as the family’s last name to 
confirm ethnicity. Data on maternal smoking 
and alcohol use during and in the 3 months 
before pregnancy were also collected. History 
of maternal illness was also obtained, which 
included respiratory symptoms, asthma, or 
allergy during pregnancy or in the 3 months 
before pregnancy. At the 6- and 16-month 
follow-up visits, mothers again completed 
a questionnaire that updated demographic 
and lifestyle information and data on current 
maternal smoking and collected data on the 
child’s day care attendance and breast-feeding. 
Infant medical records. The infant’s medi-
cal records were abstracted at birth and 6 and 
16 months to obtain birth weight, gestational 
age (weeks), and the child’s weight taken at 
well- and sick-child visits with their pediatri-
cians. Because these office visits did not neces-
sarily coincide with the dates of their thymus 
measurements at 6 and 16 months, we inter-
polated linearly the two weights closest in time 
both before and after the thymus measure-
ment date to estimate the child’s weight at the 
time of thymus measurement.
Statistical methods. Selection of PCBs 
for statistical models. We selected maternal 
and infant PCB congeners for inclusion in 
our statistical models if at least 80% of the 
  measurements were above the limit of detec-
tion (LOD) in maternal and 6- and 16-month 
serum samples. These were congeners 138+163, 
153, 170, and 180. When an individual conge-
ner value was below the LOD, we assigned the 
value as the LOD divided by the square root 
of 2 (Lubin et al. 2004). The sum PCB vari-
able is therefore the arithmetic sum of these 
four congeners.
Table 1. Characteristics of infants and mothers 
who contributed at least one observation to the 
mixed model (n = 1,056).
Characteristic n (%)a
District
Michalovce 760 (72)
Svidnik 296 (28)
Infant sex
Male 539 (51)
Female 517 (49)
Gestation length (weeks)
< 37 25 (2)
37–41 1,001 (95)
≥ 42 30 (3)
Maternal education
< 12 432 (41)
12–16 562 (53)
≥ 16 62 (6)
Marital status
Married 972 (92)
Never married 65 (6)
Widowed 4 (0)
Divorced/separated 15 (1)
Months of exclusive breast-feeding
0 to < 3 495 (47)
3–6 543 (51)
> 6 18 (2)
Ethnicity of child
Romani 224 (21)
Slovak/eastern European 832 (79)
Maternal age at child’s birth (years)
18 to < 20 91 (9)
20–30 784 (74)
> 30 181 (17)
aPercentages may not sum to 100 because of rounding.PCBs and infant thymus size
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Multivariate methods. To eliminate dif-
ferences in thymic volume measures attribut-
able to different examiners, we standardized 
thymic volume by examiner and within each 
time point (birth and 6 and 16 months of 
age). We fit repeated measures models that 
included a repeated measure of standardized 
thymus volume at birth and 6 and 16 months 
of age as the dependent variable. One set of 
models focused on maternal PCB concentra-
tion in relation to all three thymus volume 
measurements; the other examined time-
varying PCB exposure based on maternal and 
6- and 16-month infant PCB concentrations 
as the exposure of interest. Continuous PCB 
concentrations (per lipid basis, in nanograms 
per gram of lipid) were modeled as natural 
log values to reduce the influence of extreme 
values, and preliminary, age-specific models 
showed that the PCB–thymus volume asso-
ciation was adequately modeled with a linear 
term. To allow for age to modify the asso-
ciations between PCB concentrations and 
thymus volume, we included a PCB × age 
interaction term, where age was a categorical 
variable (0, 6, and 16 months, correspond-
ing to the month of assessment). We used 
directed acyclic graphs to select covariates for 
our model (Greenland et al. 1999), which 
included ethnicity (Romani/other), infant sex, 
district of residence (Svidnik/Michalovce), 
infant weight (kilograms), and duration of 
exclusive breast-feeding (months). Infant 
weight was modeled as a time-varying covari-
ate using the recorded birth weight and the 
interpolated weight at 6 and 16 months of 
age, as described above. Duration of exclu-
sive breast-feeding was also parameterized as a 
time-varying covariate and included an inter-
action with categorical time, so that separate 
effects could be estimated at 6 and 16 months 
of age. Duration of exclusive breast-feeding 
values at birth were set equal to 0 (because 
women were not yet breast-feeding), and val-
ues at 6 and 16 months corresponded to the 
duration of exclusive breast-feeding up until 
that point in time. All models were fit using 
the MIXED procedure in SAS (version 9.2; 
SAS Institute Inc., Cary, NC, USA) with ran-
dom effects specified for intercept and age at 
assessment (weeks), with no explicit structure 
assumed for the   covariance among repeated 
measures (“unstructured covariance”). Because 
only a portion (n = 249) of 6-month infant 
PCB samples were analyzed, and the speci-
mens selected for analysis were selected based 
on maternal PCB concentration (stratified ran-
dom sampling), sampling weights were added 
for the 6-month time point (weights were set 
to 1 at birth and 16 months of age). Finally, 
to facilitate interpretability and for consistency 
with a previous study of PCBs and infant thy-
mus size from this cohort (Park et al. 2008), 
we present the results for regression models 
as the difference in standardized thymus vol-
ume [and associated 95% confidence intervals 
(CIs)] for an increase in PCB concentration 
from the 10th to the 90th percentile. In addi-
tion to our primary model (described above), 
we limited our study sample to those infants 
who had thymus measures conducted within 
the first postnatal week and within 2 weeks 
of their 6- and 16-month birthdays. Results 
using the truncated age range are presented 
alongside our primary model for comparison.
We also conducted two sensitivity analyses 
to evaluate the role of exclusive breast-feeding 
duration on PCB concentrations and thymus 
development. First, we fit 6- and 16-month 
PCB models without adjustment for breast-
feeding to evaluate the role of confounding, 
and second, we also examined potential het-
erogeneity by exclusive breast-feeding duration 
at the 6- and 16-month time points. Results of 
the sensitivity analyses are reported in text.
Results
Baseline sample characteristics. Table 1 depicts 
characteristics of the 1,056 mother–  infant 
pairs who contributed at least one observa-
tion to the repeated measures model (93% of 
the original cohort). Nearly three-quarters of 
these families lived in the Michalovce district, 
17% of the mothers were ≥ 30 years of age, 
59% had at least 12 years of education, and 
the vast majority (92%) were married and liv-
ing with their partners. Just over half (53%) 
of mothers exclusively breast-fed their infant 
for at least 3 months.
PCB concentrations. Maternal and 6- and 
16-month infant sum PCB concentrations 
(congeners 138+163, 153, 170, and 180) are 
presented in Table 2, as well as PCB-153 con-
centrations for purposes of comparison with 
other populations (Longnecker et al. 2003). 
The median maternal PCB-153 concentration 
was 143 ng/g lipid (10th percentile, 62 ng/g 
lipid; 90th percentile, 369 ng/g lipid) and 
Table 2. PCB concentrations in maternal and 6- and 16-month serum samples of mother–infant pairs contributing at least one observation to the mixed model.a
Wet weight (ng/mL) Per lipid (ng/g or ppb)
PCB measure n Mean Min P10 P25 P50 P75 P90 Max Mean Min P10 P25 P50 P75 P90 Max
Maternal PCB
Sumb 966 6.09 0.46 1.76 2.68 4.18 6.92 11.68 153.93 591 49 183 267 415 660 1,110 10,853
PCB-153 966 2.03 0.11 0.61 0.92 1.42 2.29 3.92 56.13 197 11 62 91 143 220 369 3,958
6-month PCBc
Exclusively breast-fed < 3 months
Sumb 98 1.40 0.02 0.16 0.27 0.53 1.37 3.36 31.29 233 4 26 51 94 232 544 3,027
PCB-153 98 0.51 0.01 0.08 0.11 0.20 0.54 1.13 3.300 85 2 13 20 35 85 189 1,089
Exclusively breast-fed ≥ 3 months
Sumb 112 4.68 0.13 0.60 1.74 3.11 5.08 9.30 138.34 821 24 103 278 586 890 1,348 28,540
PCB-153 112 1.64 0.05 0.22 0.57 1.15 1.75 3.30 46.56 288 10 39 91 206 306 503 9,606
All infants
Sumb 210 3.19 0.02 0.21 0.42 1.74 3.91 6.51 138.3 553 4 37 87 278 726 1,231 28,540
PCB-153 210 1.12 0.01 0.09 0.17 0.62 1.42 2.10 46.56 195 2 15 33 98 264 396 9,606
16-month PCB
Exclusively breast-fed < 3 months
Sumb 311 1.81 0.01 0.19 0.32 0.61 1.33 3.51 74.24 305 2 34 54 104 230 564 11,164
PCB-153 311 0.61 0.00 0.07 0.12 0.24 0.52 1.25 14.00 103 1 12 20 39 85 207 2,036
Exclusively breast-fed ≥ 3 months
Sumb 435 4.72 0.01 0.62 1.53 2.89 5.61 10.31 46.84 805 2 114 264 503 942 1,679 10,122
PCB-153 435 1.68 0.00 0.24 0.56 1.04 1.94 3.55 16.21 287 0 43 95 183 341 563 3,504
All infants
Sumb 746 3.51 0.01 0.27 0.57 1.66 3.99 7.86 74.24 597 2 49 100 292 707 1,321 11,164
PCB-153 746 1.23 0.00 0.10 0.21 0.62 1.46 2.74 16.21 210 0.5 18 37 106 254 461 3,504
Abbreviations: Max, maximum; Min, minimum; P, percentile.
aValues reflect the distributions after imputation of values below the LOD. bSum of PCB congeners 138+163, 153, 170, and 180. cWeighted to reflect underlying distribution of 6-month 
PCB concentrations in the cohort.Jusko et al.
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ranged from 11 to 3,958 ng/g lipid. Compared 
with maternal serum concentrations, median 
PCB-153 concentrations were lower in infants 
at 6 months (98 ng/g lipid) and 16 months 
(106 ng/g lipid). When infant PCB concen-
trations were considered separately by dura-
tion of exclusive breast-feeding, results showed 
that infants who were exclusively breast - fed for 
≥ 3 months had higher PCB concentrations 
than those exclusively breast - fed for a shorter 
duration, both for the sum PCB concentration 
and for PCB-153.
Lipid-adjusted maternal sum PCB concen-
tration was moderately associated with 6-month 
infant (Spearman r = 0.49) and 16-month 
infant (Spearman r = 0.33) lipid-adjusted 
sum PCB concentrations. Six- and 16-month 
infant lipid-adjusted PCB concentrations were 
strongly associated (Spearman r = 0.92). Results 
were similar when sum PCB concentrations 
were expressed as wet-weight concentrations.
Thymus ultrasound measures. The median 
(SD) non  standardized thymus index was 
8.7 (4.5) at birth, 14.1 (7.1) at the 6-month 
follow-up, and 9.4 (7.5) at the 16-month fol-
low-up. Most (85%) neonatal thymus examina-
tions were conducted within the first week of 
birth, with a maximum delay of 4 weeks. The 
median age was 26 weeks (range, 24–48 weeks) 
at the 6-month thymus examination and 
70 weeks (range, 66–88 weeks) at the 16-month 
follow-up.
PCB concentrations and infant thymus 
index. Table 3 shows the results of a repeated 
measures regression model predicting stan-
dardized thymus volume as a function of 
PCB concentration, adjusting for potential 
confounding variables. An increase in sum 
maternal serum PCB concentration from the 
10th to the 90th percentile was associated 
with a 0.21-SD reduction in thymus volume 
at birth (95% CI: –0.37, –0.05); maternal 
sum PCB concentrations were not associated 
with measures of thymus volume at 6 and 
16 months of age. Six-month infant PCBs 
were associated with reduced thymus volume 
at 6 months of age (a 0.40-SD reduction for 
an increase in sum serum PCB concentra-
tion from the 10th to the 90th percentile), 
although the CI for this estimate was wide 
(95% CI: –0.76, –0.04). There was some sug-
gestion that 16-month infant PCB concentra-
tion was positively associated with thymus 
volume assessed at 16 months of age (0.17-SD 
increase; 95% CI: –0.04, 0.38).
When we limited our statistical models 
to the subset of infants with thymus mea-
surements within the first week of birth and 
within 2 weeks of their 6- and 16-month 
birthdays, results were generally further away 
from the null hypothesis (Table 3), although 
the reduction in sample size also decreased the 
precision of our estimates. Additionally, infant 
weight, Romani ethnicity, and male sex were 
positively associated with thymus volume in 
our models (data not shown). Duration of 
exclusive breast-feeding was also positively 
associated with thymus volume, but only at 
6 months of age (data not shown).
When we did not adjust for duration 
of exclusive breast-feeding, the association 
between 6-month infant PCB and 6-month 
thymus was attenuated (0.26-SD reduction 
for an increase in 6-month infant PCB con-
centration from the 10th to the 90th per-
centile; 95% CI: –0.57, 0.06). In addition, 
when we included breast-feeding duration, 
time of assessment, and PCB concentration 
in a three-way interaction model, we did not 
observe evidence of heterogeneity in the asso-
ciation between PCBs and thymus volume 
according to breast - feeding status (p for inter-
action = 0.91).
Discussion
The present study was designed to address two 
related research questions: first, whether higher 
in utero PCB concentrations are associated 
with smaller thymus volumes later in infancy; 
and second, whether infant PCB concentra-
tions measured at 6 and 16 months of age were 
inversely associated with concurrent thymus 
volume measurements. Results from our study 
show that a) although higher maternal PCB 
concentrations are associated with a smaller 
thymus volume at birth, they are not associ-
ated with thymus volume beyond the neonatal 
period, and b) thymus volume at 6 months of 
age is more strongly associated with concur-
rently measured infant PCB concentrations 
than with maternal PCB concentrations.
In this eastern Slovak population, we 
observed smaller thymus volumes in relation 
to measures of maternal and infant PCB con-
centrations, which included predominantly 
non-dioxin-like congeners. However, much 
of the experimental literature concerning thy-
mic atrophy and persistent organic pollut-
ants deals with exposure to TCDD and other 
coplanar PCBs (e.g., PCB-126) as the expo-
sure of interest. In these studies, TCDD acts 
as a model compound for immune suppres-
sion because it strongly binds the aryl hydro-
carbon (Ah) receptor (Safe 1994; Silkworth 
et al. 1984; Tryphonas and Feeley 2001), an 
intracellular protein that regulates the induc-
tion of cytochrome P450 enzymes. The Ah 
receptor is found in many cells of the immune 
system, including the thymus, and is funda-
mental to TCDD-induced immunotoxicity. 
For instance, mice lacking the Ah receptor 
have been observed to be highly resistant to the 
effects of TCDD, exhibiting normal cellular 
and humoral immune responses (Vorderstrasse 
et al. 2001) and lacking evidence of thymic 
atrophy (Fernandez-Salguero et al. 1996). 
Concentrations of non  coplanar PCBs (which 
are typically the most prevalent congeners 
in human serum) are moderately correlated 
with dioxin-like activity in several popula-
tions, including those in eastern Slovakia. For 
instance, in a study of reproductive-age women 
in Belgium (Pauwels et al. 2000), serum con-
centrations of PCB congeners 118, 138, 153, 
and 180 were each positively correlated, with 
chemically activated luciferase expression 
(CALUX) toxic equivalent (TEQ) values of 
0.34 ≤ r ≥ 0.39, as was the sum of these four 
congeners (Pearson r = 0.43). In serum spec-
imens collected from 300 men and women 
in eastern Slovakia as part of the PCBRISK 
project (Petrik et al. 2006), concentrations 
Table 3. Adjusted change in infant thymus volume at birth and 6 and 16 months of age in relation to 
maternal and 6- and 16-month infant PCB concentrations.
Model na Change in thymus index [SD (95% CI)]b 
Maternal PCBc
Thymus index at birth
Primary modeld 966 –0.21 (–0.37, –0.05)
Truncated age rangee 951 –0.23 (–0.38, –0.07)
Thymus index at infant 6 months
Primary model 761 –0.09 (–0.29, 0.11)
Truncated age range 644 –0.14 (–0.26, 0.07)
Thymus index at infant 16 months
Primary model 721 –0.02 (–0.21, 0.17)
Truncated age range 519 0.09 (–0.13, 0.07)
6-month infant PCBc
Thymus index at 6 months
Primary model 210 –0.40 (–0.76, –0.04)
Truncated age range 186 –0.54 (–0.94, 0.13)
16-month infant PCBc
Thymus index at 16 months
Primary model 746 0.17 (–0.04, 0.38)
Truncated age range 538 0.24 (–0.01, 0.49)
aNumber of observations for each PCB–thymus association; owing to the repeated measure model, the total number of 
unique observations in each statistical model was always greater. bEstimated change in standardized infant thymus volume 
as PCB concentration increases from the 10th to the 90th percentile. cSum of PCB congeners 138+163, 153, 170, and 180. 
dAdjusted for ethnicity (Romani/other), sex, weight (in kilograms; time-varying), district of residence (Svidnik/Michalovce), 
and duration of exclusive breast-feeding (months). eAdjusted (as in primary model) results for the subset of infants with 
thymus measurements performed within 1 week of birth or within 2 weeks of reaching 6 and 16 months of age. PCBs and infant thymus size
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of PCB congeners 138, 153, 170, and 180 
were positively associated with the total WHO 
(Van den Berg et al. 2006) TEQ (Spearman r 
≥ 0.58) (Kocan A, personal communication). 
Thus, although we did not measure coplanar 
PCB congeners in our study and our analyses 
focused on the association between thymus 
volume and non  coplanar PCBs, the moder-
ately strong correlations between non-dioxin-
like PCB concentrations and total TEQ in this 
population suggest that the observed decreases 
in thymus volume may be the result of dioxin-
like activity, mediated through the Ah receptor. 
Therefore, results from experimental studies 
involving TCDD (discussed below) may never-
theless be relevant in guiding causal inference.
The first finding from this study indicates 
that although higher maternal PCBs are associ-
ated with reduced thymus size at birth [a find-
ing previously reported by Park et al. (2008) in 
this cohort)], maternal PCB concentrations are 
not associated with later thymus measures at 
6 and 16 months of age. This finding appears 
to coincide with the results of experimental 
studies where pregnant mice were dosed with 
TCDD during gestation, and thymic develop-
ment was followed in their offspring. In one of 
these studies, a single maternal dose of TCDD 
(10 μg/kg body weight) was given on gesta-
tional day 14, and thymic development was 
assessed on postnatal days (PNDs) 4, 7, 11, 
and 18 in the pups (Fine et al. 1989). Results 
showed differences in thymus weight (as a 
proportion of body weight) and thymic cel-
lularity between treatment and control groups 
for PNDs 4–11, but by PND18 both thymic 
weight and cellularity were similar between 
control and treatment groups. Another study 
dosed pregnant mice with TCDD on gesta-
tional days 6–14 and examined thymic cellu-
larity in offspring at PNDs 6, 14, and 21 and 
at 7, 8, and 10 weeks (Holladay et al. 1991). 
Although differences in thymic cellularity 
were observed on PND6, by PND14 thymic 
cellularity was similar for treated and control 
groups. These findings from experimental stud-
ies and the results of the present study suggest 
that the association between in utero exposure 
to dioxin-like compounds and thymic vol-
ume may be limited to the neonatal period. 
However, the impact on functional immuno-
competence over time is unclear.
The second finding from our study indi-
cates that 6-month infant PCB concentrations 
are inversely associated with thymus volume 
at age 6 months. Moreover, we observed a 
larger decrease in thymus volume at 6 months 
associated with the 6-month PCB measure 
compared with in utero PCB exposure. This 
suggests that the thymus is sensitive to the 
potential effects of PCBs beyond the prena-
tal period, a finding also observed in experi-
mental studies of TCDD (Faith and Luster 
1979). In our population, thymus size peaked 
at approximately 6 months of age and then 
decreased by 16 months of age, consistent 
with previous studies documenting the devel-
opment of the thymus in humans (George 
and Ritter 1996; Hasselbalch et al. 1997; 
Steinmann et al. 1985). These results suggest 
that 6 months of age is not only the time of 
maximum thymus volume during infancy but 
may also be the period of greatest sensitivity 
to PCBs. This finding should be interpreted 
cautiously, however, because our estimate of 
6-month infant PCBs and thymus volume was 
relatively imprecise. In addition, we noted that 
the association between 6-month infant PCB 
concentration and 6-month thymus volume 
was stronger when adjusting for breast-  feeding. 
Because length of exclusive breast - feeding is 
positively associated with both infant PCB 
concentration and thymus volume,   unadjusted 
estimates of the PCB–thymus association at 
6 months would tend to underestimate the 
adverse association between infant PCB 
  concentration and thymus volume.
Finally, we did observe some evidence 
of a positive association between 16-month 
PCB concentration and 16-month thymus 
volume. Because the thymus size peaks at 
approximately 8 months of age and then 
shrinks (Hasselbalch et al. 1997), a larger thy-
mus volume at 16 months could occur if the 
shrinkage occurred later than expected, rep-
resenting delayed maturation of the thymus. 
That is, infants with a smaller thymic volume 
at 6 months may reach their peak later, and 
the decline by 16 months may be less than 
would occur in those whose thymus reached 
a peak at the typical time point. The actual 
functional significance in terms of lympho-
cyte differentiation and maturation is unclear, 
and any possible mechanism should be inter-
preted cautiously given the lack of precision 
we observed in our estimate of PCBs and thy-
mus volume at 16 months.
Some limitations of our study deserve dis-
cussion. First, because of the low concentra-
tions of coplanar PCBs and other dioxin-like 
compounds in our study and the high cost to 
quantitate them, we were unable to measure 
these compounds in maternal and infant sera. 
Second, only a portion of 6-month infant 
serum samples was analyzed for PCB concen-
trations, and although our stratified random 
sampling scheme had the benefit of increasing 
statistical power (relative to a similar size sam-
ple selected at random), CIs for the estimate 
of 6-month PCB concentration and 6-month 
thymus volume indicated that the estimate 
was relatively imprecise.
The present study has many strengths, 
which include a biomarker of PCB exposure 
as opposed to surrogate measures (e.g., breast-
feeding duration, fish consumption), as well 
as repeated assessments of thymus volume 
during infancy. Repeated measures of both 
PCB concentration and thymus volume pro-
vided more specificity in terms of the timing 
of exposure and potential adverse outcomes 
and greater statistical power. To our knowl-
edge, this is the first study to directly assess 
thymus volume over time in relation to a sus-
pected human toxicant. Finally, the validity 
of measurements in this cohort is supported 
by the concordance with the extant litera-
ture. Similar to our results, others have found 
breast-feeding and measures of growth such as 
birth weight and birth length to be associated 
with larger thymic index (Benn et al. 2001; 
Hasselbalch et al. 1997; Iscan et al. 2000; 
Yekeler et al. 2004).
Taken together, the present study suggests 
that the association between in utero exposure 
to PCBs and thymus volume may be limited to 
the neonatal period, although thymus volume 
measures later in infancy may be affected by 
postnatal PCB exposures. Whether reductions 
in thymus volume are associated with compro-
mised immune function or increased morbidity 
in this population remains to be seen.
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